Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Patient recruitment ongoing in phase I/II study of imaging agent 89Zr-DFO-daratumumab

Oct. 8, 2018

Fluorescent virus-guided cytology detects active cancer cells in peritoneally disseminated GC

Oct. 5, 2018

Quinoline-based tracers targeting FAP show theranostic potential

Oct. 3, 2018

Optimized neuroimaging with fluorine-18-labeled SV2A PET tracers

Sep. 28, 2018

SGM-101 is safe and effective for intraoperative imaging of pancreatic ductal adenocarcinoma

Sep. 28, 2018

PET tracer for renal imaging tested in vivo

Sep. 21, 2018

First-in-human data for CCR2-targeted PET tracer [64Cu]DOTA-ECL-1i

Sep. 18, 2018

Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease

Sep. 17, 2018

Progenics reports topline phase III data on 1404 in low-grade prostate cancer

Sep. 13, 2018

Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints

Sep. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...